학술논문
Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma
Document Type
Article
Author
Source
In Blood Advances 14 November 2023 7(21):6579-6588
Subject
Language
ISSN
2473-9529